The Effectiveness of Idazoxan in Treating TRD

Sheba Medical Center

Status and phase: Withdrawn; Phase 3

Conditions: Major Depressive Disorder

Treatments: Drug: Idazoxan

Study type: Interventional

Funder types: Other

Identifiers

NCT00294944

SHEBA-05-3911-JZ-CTIL

Details and patient eligibility

About

Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• MDD patients
• Did not respond to at least one treatment of 4-6 weeks of SSRI in adequate dose
• In or out patients

Exclusion criteria

• Psychotic symptoms